Certainly some ground breaking stuff going on for Antisense Gen2. We are now very much on the road to proving oligonucleotide therapeutics as the third major drug discovery platform alongside small molecules and biologics.
Former Pfizer Exec Sees Oligo Drugs Becoming Major Platform
ISIS share price should continue its strong uptrend on this news as it moves to price in the likihood of success and the validation of the platform.
Great stuff, Good Luck!
fda gives thumbs up to antisense !! , page-22
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.9¢ |
Change
-0.046(34.1%) |
Mkt cap ! $78.88M | |||
| Open | High | Low | Value | Volume |
| 8.7¢ | 9.0¢ | 8.6¢ | $1.849M | 21.18M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 679941 | 8.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.9¢ | 761717 | 5 |
View Market Depth
| Last trade - 13.15pm 18/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |